A carregar...
Use of early chemotherapy for hormone-sensitive prostate cancer: time for CHAARTED
CHAARTED was an ECOG-led phase III trial looking at early chemotherapy with the use of docetaxel in addition to androgen deprivation therapy (ADT) versus ADT alone in hormone-sensitive prostate cancer. The positive results of the trial showing marked improvement in overall survival in those who rece...
Na minha lista:
| Publicado no: | Asian J Androl |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4854101/ https://ncbi.nlm.nih.gov/pubmed/26510505 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.164920 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|